1. Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients
- Author
-
Jiang C, Hu WM, Liao FX, Yang Q, Chen P, Rong YM, Guo GF, Yin CX, Zhang B, He WZ, and Xia LP
- Subjects
Overall survival ,Biomarker ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 ,Neutrophil-to-lymphocyte ratio ,GIST - Abstract
Chang Jiang,1–3,* Wan-Ming Hu,2–4,* Fang-Xin Liao,1–3 Qiong Yang,1–3 Ping Chen,1–3 Yu-Ming Rong,1–3 Gui-Fang Guo,1–3 Chen-Xi Yin,2,3,5 Bei Zhang,1–3 Wen-Zhuo He,1–3 Liang-Ping Xia1–3 1VIP Department, Sun Yat-sen University Cancer Center, 2State Key Laboratory of Oncology in South China, 3Collaborative Innovation Center for Cancer Medicine, 4Department of Pathology, 5Intensive Care Unit, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China *These authors contributed equally tothis work Purpose: To investigate the prognostic relevance of preoperative peripheral neutrophil-to-lymphocyte ratio (NLR) in gastrointestinal stromal tumor (GIST) patients.Materials and methods: We enrolled 129 consecutive GIST patients who underwent initial curative surgical resection with or without adjuvant/palliative imatinib treatment in our study. Blood NLR was calculated as neutrophil count (number of neutrophils ×109/L) divided by lymphocyte count (number of lymphocytes ×109/L). Survival curves were constructed by using the Kaplan–Meier method. Univariate and multivariate Cox proportional hazard regression models were performed to identify associations with outcome variable. All tests were two-sided, and P
- Published
- 2016